HOME › DRUGS › MARALIXIBAT CHLORIDE
ACTIVE SUBSTANCE / INN

MARALIXIBAT CHLORIDE

Brand name(s): LIVMARLI, Livmarli
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Alagille Syndrome
NDA214662
ACTIVE SUBSTANCE
Maralixibat Chloride
REGULATORS
FDA · EMA
SPONSORS / MAH
MIRUM, Mirum Pharmaceuticals International B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LIVMARLINDA214662MIRUMPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LivmarliMirum Pharmaceuticals International B.V.Authorised09/12/2022Alagille Syndrome

FULL INTELLIGENCE ON MARALIXIBAT CHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →